To further elucidate the association between SLC38A2, the TME, and tumor-associated cells, we utilized single-cell sequencing data analysis (Li et al., 2023c; Ding et al., 2024) to evaluate the expression patterns of SLC38A2 across 12 types of cancer. This evidence concerns the gene SLC38A2 and neoplasm.